[go: up one dir, main page]

WO2008105445A1 - Composition pharmaceutique transdermique - Google Patents

Composition pharmaceutique transdermique Download PDF

Info

Publication number
WO2008105445A1
WO2008105445A1 PCT/JP2008/053376 JP2008053376W WO2008105445A1 WO 2008105445 A1 WO2008105445 A1 WO 2008105445A1 JP 2008053376 W JP2008053376 W JP 2008053376W WO 2008105445 A1 WO2008105445 A1 WO 2008105445A1
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
transdermal
transdermal pharmaceutical
eptazocine hydrobromide
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/053376
Other languages
English (en)
Japanese (ja)
Inventor
Takayuki Furuishi
Kazuo Tomono
Toyofumi Suzuki
Toshiro Fukami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon University
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nihon University
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon University, Nippon Zoki Pharmaceutical Co Ltd filed Critical Nihon University
Priority to JP2009501265A priority Critical patent/JP5230596B2/ja
Publication of WO2008105445A1 publication Critical patent/WO2008105445A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

L'invention porte sur une composition pharmaceutique transdermique caractérisée par le mélange de bromhydrate d'eptazocine avec un ester d'acide gras, un ester d'acide gras et de glycérol et un glycol ou une pyrrolidone. L'invention porte également sur un procédé d'amélioration de l'absorption transdermique du bromhydrate d'eptazocine. L'absorption cutanée du bromydrate d'eptazocine de la composition pharmaceutique transdermique est améliorée de manière significative, et permet la pénétration cutanée d'une quantité désirée de bromhydrate d'eptazocine sans devoir recourir à une injection. Par conséquent, la composition pharmaceutique transdermique est hautement utile en tant que principe pharmaceutique présentant un excellent effet analgésique.
PCT/JP2008/053376 2007-03-01 2008-02-27 Composition pharmaceutique transdermique Ceased WO2008105445A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009501265A JP5230596B2 (ja) 2007-03-01 2008-02-27 経皮吸収用医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007051171 2007-03-01
JP2007-051171 2007-03-01

Publications (1)

Publication Number Publication Date
WO2008105445A1 true WO2008105445A1 (fr) 2008-09-04

Family

ID=39721270

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/053376 Ceased WO2008105445A1 (fr) 2007-03-01 2008-02-27 Composition pharmaceutique transdermique

Country Status (2)

Country Link
JP (1) JP5230596B2 (fr)
WO (1) WO2008105445A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2500038A4 (fr) * 2009-11-12 2015-03-11 Univ Nihon Composition phatmaceutique pour usage externe/

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04217920A (ja) * 1990-03-30 1992-08-07 Morimoto Kazutoshi 経皮吸収組成物
JPH09143061A (ja) * 1995-11-20 1997-06-03 Showa Denko Kk 鎮痛剤用経皮吸収製剤
JPH09315957A (ja) * 1996-05-28 1997-12-09 Hisamitsu Pharmaceut Co Inc 経皮治療用装置
WO2006085521A1 (fr) * 2005-02-10 2006-08-17 Nihon University Composition medicinale destinee a une absorption transdermique, contenant un antagoniste des recepteurs opioides, un procede de production de celui-ci et un procede destine a favoriser l’absorption transdermique de l’antagoniste

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3243564B2 (ja) * 1990-08-20 2002-01-07 リードケミカル株式会社 外用貼付剤
JPH0710754A (ja) * 1993-06-28 1995-01-13 Sekisui Chem Co Ltd 経皮吸収貼付剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04217920A (ja) * 1990-03-30 1992-08-07 Morimoto Kazutoshi 経皮吸収組成物
JPH09143061A (ja) * 1995-11-20 1997-06-03 Showa Denko Kk 鎮痛剤用経皮吸収製剤
JPH09315957A (ja) * 1996-05-28 1997-12-09 Hisamitsu Pharmaceut Co Inc 経皮治療用装置
WO2006085521A1 (fr) * 2005-02-10 2006-08-17 Nihon University Composition medicinale destinee a une absorption transdermique, contenant un antagoniste des recepteurs opioides, un procede de production de celui-ci et un procede destine a favoriser l’absorption transdermique de l’antagoniste

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FURUISHI T. ET AL.: "Shuka Suisosan Eptazocine no Keihi Kyushu ni Oyobosu Sokushinzai no Eikyo", THE PHARMACEUTICAL SOCIETY OF JAPAN DAI 127 NENKAI YOSHISHU, no. 3, 5 March 2007 (2007-03-05), pages 111 + ABSTR. NO. 29P1-AM202 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2500038A4 (fr) * 2009-11-12 2015-03-11 Univ Nihon Composition phatmaceutique pour usage externe/
AU2010319065B2 (en) * 2009-11-12 2015-03-26 Nihon University Pharmaceutical composition for external use
US9050247B2 (en) 2009-11-12 2015-06-09 Nihon University Pharmaceutical composition for external use
KR101737960B1 (ko) * 2009-11-12 2017-05-19 니혼 유니버서티 외용 의약 조성물

Also Published As

Publication number Publication date
JP5230596B2 (ja) 2013-07-10
JPWO2008105445A1 (ja) 2010-06-03

Similar Documents

Publication Publication Date Title
WO2010150995A3 (fr) Compositions de traitement de la dépendance aux drogues et d'amélioration du comportement lié aux dépendances
JO3598B1 (ar) الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP1944051A4 (fr) Appareil à poncturer, appareil à doser et méthode pour poncturer
WO2008124085A3 (fr) Méthodes d'utilisation de combinaisons d'inhibiteurs de mek et de jak-2
WO2011051354A3 (fr) Compositions pharmaceutiques transdermiques contenant des agents actifs
WO2009129464A3 (fr) Méthode permettant de traiter une douleur aiguë au moyen d'une forme retard d'une préparation combinée avec une préparation liquide
WO2009089494A3 (fr) Compositions pharmaceutiques
WO2007098128A3 (fr) Formules liquides de phényléphrine
TN2009000124A1 (en) Injectable depot composition and its process of preparation
EP4338805A3 (fr) Procédés de réduction du risque d'un événement cardiovasculaire chez un sujet soumis à un traitement par une statine
WO2007103719A3 (fr) MODULATEURS DE LA 11-β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
GT200800257A (es) Composicion farmaceutica estable que contiene docetaxel y un metodo para la fabricacion de la misma
MX2010004613A (es) Composicion topica.
MX2010010954A (es) Farmaco contra cancer de higado.
BRPI0608077A2 (pt) composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos
WO2008075192A3 (fr) Composés de ciblage et composés thérapeutiques, et microvésicules remplies de gaz comprenant lesdits composés
WO2007138466A3 (fr) Compositions pharmaceutiques comprenant une combinaison de meloxicam et de tramadol
BRPI0704008A2 (pt) uso de glicerina, método para tratamento de culturas, composição de mistura em tanque e um método para a preparação de uma composição de mistura em tanque
WO2008002514A3 (fr) Combinaison de composés pour le traitement de la toux et procédé de traitement des toux courantes
WO2011088333A3 (fr) Formulations pour anesthésie locale se solidifiant pour la gestion de la douleur
WO2008116004A3 (fr) Timbre transdermique et méthode for d'administration de vitamine b12
WO2010065194A3 (fr) Compositions et procédés pour favoriser un état de relaxation
WO2011076209A3 (fr) Composition pharmaceutique comprenant un mélange de solvants et un dérivé de la vitamine d ou analogue
WO2009035961A3 (fr) Composition de rétraction durcissable à usage dentaire, son procédé de production et son utilisation
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08720924

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009501265

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08720924

Country of ref document: EP

Kind code of ref document: A1